So far this summer, the Iowa State University Extension lab had not seen any signs of the disease in Iowa — until now. ISU ...

GLP-1 receptor agonists are among the active ingredients in so-called weight-loss injections. Originally developed to treat ...

GLP-1 compounders find loophole by altering formulations to bypass FDA bans, raising oversight concerns for weight-loss clinics nationwide.

A new report states that older adults using GLP-1 drugs may have a higher risk of loss of muscle mass, malnutrition, ...

UVM Health expects to save $19 million a year by cutting GLP-1 coverage for employees. But does that figure account for the medical costs patients avoid once the treatment works?

The GLP-1 market is currently one of the fastest-growing areas in the pharmaceutical industry. It's not surprising, then, that many drugmakers -- big and small -- are looking to capitalize on this.

MindWalk will report Q4 and full fiscal year 2026 results on July 22, 2026, giving investors a near-term look at the company's revenue traje ...

During an on-site inspection, investigators found that the semaglutide was manufactured in an unnamed lab not registered with the FDA.

A wave of new research and policy developments is reshaping how health system leaders think about GLP-1 medications — from telehealth prescribing gaps to Medicare’s new coverage bridge. Here are six ...

A new study tracking people on GLP-1 weight loss jabs has picked up on changes happening inside the body that go far beyond the number on the scales, some of which are catching experts off guard.

GLP-1 receptor agonists promote weight loss via gut-hormone mimetics that curb appetite, slow gastric emptying, and improve ...

GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health ...